Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A trypanocidal phenazine derived from beta-lapachone.

Cleverson Neves-Pinto1, Valéria R S Malta, Maria do Carmo F R Pinto

  • 1Núcleo de Pesquisas em Produtos Naturais, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, 21944-970 Rio de Janeiro, RJ, Brazil.

Journal of Medicinal Chemistry
|May 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of quinone imine and sulphur-containing compounds with antitumor and trypanocidal activities: redox and biological implications.

RSC medicinal chemistry·2021
Same author

Starvation and pH stress conditions induced mitochondrial dysfunction, ROS production and autophagy in Trypanosoma cruzi epimastigotes.

Biochimica et biophysica acta. Molecular basis of disease·2020
Same author

Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection.

Memorias do Instituto Oswaldo Cruz·2020
Same author

Synthesis, Antitrypanosomal and Antimycobacterial Activities of Coumarin N-acylhydrazonic Derivatives.

Medicinal chemistry (Shariqah (United Arab Emirates))·2020
Same author

Synthesis and Antitrypanosomal Profile of Novel Hydrazonoyl Derivatives.

Medicinal chemistry (Shariqah (United Arab Emirates))·2019
Same author

Synthesis of quinones with highlighted biological applications: A critical update on the strategies towards bioactive compounds with emphasis on lapachones.

European journal of medicinal chemistry·2019
Same journal

Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

Journal of medicinal chemistry·2026
Same journal

Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

Journal of medicinal chemistry·2026
Same journal

3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

Journal of medicinal chemistry·2026
Same journal

A Bioorthogonally Cleavable <i>N</i>-Oxide Linker for Prodrug Design: Elucidating the Structure-Cyclization Kinetics Relationships for Controlled Drug Release.

Journal of medicinal chemistry·2026
Same journal

A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

Journal of medicinal chemistry·2026
Same journal

Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

Journal of medicinal chemistry·2026
See all related articles

Researchers synthesized new naphthoquinone derivatives to treat Chagas

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Organic Synthesis

Background:

  • Chagas' disease, caused by *Trypanosoma cruzi*, lacks effective treatments.
  • Blood prophylaxis in endemic areas is also a concern.
  • Naphthoquinone derivatives are being explored as potential therapeutic agents.

Purpose of the Study:

  • To synthesize novel naphthoquinone derivatives.
  • To screen these compounds for activity against *Trypanosoma cruzi*.
  • To identify potent anti-Chagas' disease drug candidates.

Main Methods:

  • Synthesis of naphthoquinone derivatives, including a new phenazine from beta-lapachone and aniline.
  • Structural elucidation using physical data and X-ray analysis.
  • In vitro trypanocidal screening against *T. cruzi* trypomastigotes.

Related Experiment Videos

Main Results:

  • A novel phenazine derivative was successfully synthesized and characterized.
  • The new phenazine derivative exhibited significant trypanocidal activity.
  • This compound was 9 times more potent than crystal violet against *T. cruzi* trypomastigotes.

Conclusions:

  • The synthesized phenazine derivative shows promising activity against *Trypanosoma cruzi*.
  • This compound represents a potential lead for developing new drugs against Chagas' disease.
  • Further research is warranted to explore its therapeutic potential.